| Regina Sherille Davis, LPN | |
|
1408 E Franklin St, Monroe, NC 28112-5160 | |
| (704) 635-2080 | |
| (704) 636-2089 |
| Full Name | Regina Sherille Davis |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 1408 E Franklin St, Monroe, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124665773 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 068371 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Regina Sherille Davis, LPN 284 Executive Park Dr Ste 100, Concord, NC 28025-1833 Ph: (704) 939-1100 | Regina Sherille Davis, LPN 1408 E Franklin St, Monroe, NC 28112-5160 Ph: (704) 635-2080 |
News Archive
Svelte Medical Systems today announced enrollment of the final patient in the DIRECT II (Direct Implantation of Rapamycin-Eluting stents with bioabsorbable drug Carrier Technology) clinical study. DIRECT II is a prospective, randomized study comparing the safety and efficacy of the Svelte drug-eluting coronary stent Integrated Delivery System (IDS) to the Medtronic Resolute Integrity drug-eluting stent in 159 patients at 19 investigative sites.
A nuclear receptor protein, known for controlling the ability of cells to burn fat, also exerts powerful anti-inflammatory effects in arteries, suppressing atherosclerosis in mice prone to developing the harmful plaques, according to new research by scientists at the Salk Institute for Biological Studies and the Harvard School of Public Health.
MannKind Corporation today announced that it has received a Complete Response letter from the U.S. Food & Drug Administration (FDA) regarding the New Drug Application (NDA) for AFREZZA™ (insulin human [rDNA origin]) Inhalation Powder for the treatment of adult patients with type 1 and type 2 diabetes mellitus for the control of hyperglycemia.
Researchers at Mayo Clinic in Arizona and the University of Georgia (UGA) have developed a vaccine that dramatically reduces tumors in a mouse model that mimics 90 percent of human breast and pancreatic cancer cases - including those that are resistant to common treatments.
› Verified 6 days ago
Craig M Greenlee, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1408 E Franklin St, Monroe, NC 28112 Phone: 704-283-6040 | |
Gillian Edwards, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 5004 Cattail Cv, Monroe, NC 28110 Phone: 954-646-1264 | |
Samantha N Meadows, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1408 E Franklin St, Monroe, NC 28112 Phone: 704-635-2080 | |
Alison Laney, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1408 E. Franklin St., Monroe, NC 28112 Phone: 704-635-2080 | |
Jessica Tucker, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2208 W Roosevelt Blvd, Monroe, NC 28110 Phone: 704-289-9869 | |
Karen Griffin Norwood, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1408 E Franklin St, Monroe, NC 28112 Phone: 704-939-1100 |